Correlation Between OBI Pharma and Mosel Vitelic
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Mosel Vitelic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Mosel Vitelic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and Mosel Vitelic, you can compare the effects of market volatilities on OBI Pharma and Mosel Vitelic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Mosel Vitelic. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Mosel Vitelic.
Diversification Opportunities for OBI Pharma and Mosel Vitelic
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between OBI and Mosel is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Mosel Vitelic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosel Vitelic and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Mosel Vitelic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosel Vitelic has no effect on the direction of OBI Pharma i.e., OBI Pharma and Mosel Vitelic go up and down completely randomly.
Pair Corralation between OBI Pharma and Mosel Vitelic
Assuming the 90 days trading horizon OBI Pharma is expected to under-perform the Mosel Vitelic. But the stock apears to be less risky and, when comparing its historical volatility, OBI Pharma is 1.51 times less risky than Mosel Vitelic. The stock trades about -0.12 of its potential returns per unit of risk. The Mosel Vitelic is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 3,260 in Mosel Vitelic on September 1, 2024 and sell it today you would earn a total of 190.00 from holding Mosel Vitelic or generate 5.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
OBI Pharma vs. Mosel Vitelic
Performance |
| Timeline |
| OBI Pharma |
| Mosel Vitelic |
OBI Pharma and Mosel Vitelic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OBI Pharma and Mosel Vitelic
The main advantage of trading using opposite OBI Pharma and Mosel Vitelic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Mosel Vitelic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosel Vitelic will offset losses from the drop in Mosel Vitelic's long position.| OBI Pharma vs. TaiMed Biologics | OBI Pharma vs. PharmaEngine | OBI Pharma vs. Medigen Biotechnology | OBI Pharma vs. TTY Biopharm Co |
| Mosel Vitelic vs. Winbond Electronics Corp | Mosel Vitelic vs. Macronix International Co | Mosel Vitelic vs. United Microelectronics | Mosel Vitelic vs. VIA Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |